New Delhi, October 23 (Udaipur Kiran): The domestic stock market opened on a strong note today, witnessing a sharp rise in early trade. For the first time since September 30, 2024, the Sensex opened above the 85,000 mark and the Nifty crossed the 26,000 level. After the opening rally, some profit booking briefly led to … Read more
Mumbai, September 9 (Kiran News) — Shares of Infosys surged over 4 percent on Tuesday after its subsidiary Infosys Finacle, part of EdgeVerve Systems, announced the deployment of its Finacle Digital Banking Solution Suite for PT Bank CTBC Indonesia, a subsidiary of Taiwan’s CTBC Group. The suite has been deployed on a cloud-hosted model as … Read more
Infosys is currently trading at Rs. 1468.00, up by 28.00 points or 1.94% from its previous closing of Rs. 1440.00 on the BSE. The scrip opened at Rs. 1440.00 and has touched a high and low of Rs. 1473.00 and Rs. 1439.90 respectively. So far 93470 shares were traded on the counter. The BSE group … Read more
Infosys is currently trading at Rs. 1587.90, up by 25.55 points or 1.64% from its previous closing of Rs. 1562.35 on the BSE. The scrip opened at Rs. 1560.05 and has touched a high and low of Rs. 1590.90 and Rs. 1560.05 respectively. So far 29854 shares were traded on the counter. The BSE group … Read more
Infosys is currently trading at Rs. 1550.40, up by 0.80 points or 0.05% from its previous closing of Rs. 1549.60 on the BSE. The scrip opened at Rs. 1570.00 and has touched a high and low of Rs. 1570.00 and Rs. 1537.70 respectively. So far 4586555 shares were traded on the counter. The BSE group … Read more
Infosys has reported results for first quarter ended June 30, 2022. The company has reported a marginal rise of 3.77% in its net profit at Rs 4,901 crore for the quarter under review as compared to Rs 4,723 crore for the same quarter in the previous year. Total income of the company increased by 24.26% … Read more
Infosys has inked definitive agreement to acquire BASE life science, a leading technology and consulting firm in the life sciences industry, in Europe. The acquisition reaffirms the company’s commitment to help global life sciences companies realize business value from cloud-first digital platforms and data, to speed-up clinical trials and scale drug development, positively impacting lives … Read more
